scispace - formally typeset
L

Lynn Sadler

Researcher at University of Auckland

Publications -  96
Citations -  3499

Lynn Sadler is an academic researcher from University of Auckland. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 27, co-authored 83 publications receiving 3029 citations. Previous affiliations of Lynn Sadler include Auckland City Hospital.

Papers
More filters
Journal ArticleDOI

Stillbirths: recall to action in high-income countries

TL;DR: In high-income countries, a woman living under adverse socioeconomic circumstances has twice the risk of having a stillborn child when compared to her more advantaged counterparts and programs at community and country level need to improve health in disadvantaged families.
Journal ArticleDOI

Treatment for cervical intraepithelial neoplasia and risk of preterm delivery.

TL;DR: LEEP and laser cone treatments were associated with significantly increased risk of pPROM, and careful consideration should be given to treatment of CIN in women of reproductive age, especially when treatment might reasonably be delayed or targeted to high-risk cases.
Journal ArticleDOI

The association of hysterectomy and menopause: a prospective cohort study

TL;DR: To determine whether or not hysterectomy leads to an earlier onset of the menopause, a large number of women with a history of female pattern baldness and pre-menopause preoperatively undergo hystering.
Journal ArticleDOI

Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves

TL;DR: This study aims to compare pregnancy outcomes and cardiac complications in women with either mechanical or bioprosthetic valves at the mitral site or mechanical valves treated with warfarin or subcutaneous heparin.
Journal ArticleDOI

Treatment for cervical intraepithelial neoplasia and risk of preterm delivery

TL;DR: LEEP and laser cone treatments were associated with significantly increased risk of pPROM, and care should be given to treatment of CIN in women of reproductive age, especially when treatment might reasonably be delayed or targeted to high-risk cases.